This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "osteoarthritis_cartilage_degradation#Matrix-Degrading Enzyme Upregulation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding chondrocyte cell type, biological processes, and causal edges, specialized to their context. Key substitutions: post-traumatic OA substitutes a discrete joint-injury trigger (ligament/meniscal injury) for the chronic-overload trigger; genetic OA (e.g., type II collagenopathies, ACAN/aggrecan defects) substitutes the primary ECM/structural lesion upstream of chondrocyte stress while preserving the downstream matrix-degradation chain.
Mechanical Overload and Chondrocyte Stress
trigger
Abnormal mechanical loading or acute joint injury imposes excessive stress on articular chondrocytes, the sole resident cell of cartilage. Across primary/idiopathic, post-traumatic, and genetic OA the initiating insult varies (chronic malalignment or obesity-related overload, discrete ligament/meniscal trauma, or an intrinsic ECM/structural weakness), but the response converges on a chondrocyte stress program that initiates the catabolic cascade and primes the cell for apoptosis and matrix degradation.
Downstream
-
Catabolic Chondrocyte Phenotype and Cytokine Signaling
Catabolic Chondrocyte Phenotype and Cytokine Signaling
amplifier
Stressed chondrocytes shift from a quiescent matrix-maintaining phenotype to a catabolic, hypertrophic-like state. Proinflammatory cytokines, principally IL-1beta and TNF, are produced within the joint (by chondrocytes and by synovial macrophages) and act in autocrine and paracrine loops to sustain a low-grade inflammatory environment. This cytokine signaling reprograms chondrocyte gene expression toward catabolism, suppressing anabolic matrix synthesis and inducing the matrix-degrading enzymes that execute cartilage breakdown.
Downstream
-
Matrix-Degrading Enzyme Upregulation
Matrix-Degrading Enzyme Upregulation
central effector
Catabolic chondrocyte signaling upregulates the key matrix-degrading enzymes of OA: the collagenase MMP-13, which cleaves the type II collagen fibrillar network, and the aggrecanase ADAMTS-5, which cleaves aggrecan. Aggrecan loss is an early event that exposes the collagen network to enzymatic and mechanical attack; collagen degradation that follows is essentially irreversible. This proteolytic step is the central effector that converts chondrocyte catabolism into structural matrix destruction.
Downstream
-
Cartilage Matrix Loss and Subchondral Bone Remodeling
Cartilage Matrix Loss and Subchondral Bone Remodeling
effector
Sustained proteolysis produces progressive loss of the cartilage matrix as aggrecan and collagen are depleted faster than they can be replaced. Loss of the load-bearing matrix alters joint mechanics and couples to the subchondral bone, which undergoes increased turnover, plate sclerosis, and osteophyte (new bone and cartilage) formation at the joint margins. These cartilage and bone changes are mechanically and biochemically coupled and together remodel the whole-joint architecture.
Downstream
-
Joint Cartilage Degradation with Pain and Functional Impairment
Joint Cartilage Degradation with Pain and Functional Impairment
consequence
The convergent endpoint is osteoarthritis itself: degradation of articular cartilage with whole-joint structural change producing chronic joint pain, stiffness, and progressive functional impairment and disability. OA pain is nociceptive but increasingly recognized as a complex condition involving local inflammation across joint structures and peripheral/central sensitization, and it is the dominant cause of the disability and socioeconomic burden of the disease.